BioRestorative Therapies (BRTX) Research & Development (2011 - 2026)
BioRestorative Therapies (BRTX) recorded Research & Development of $1.93 million in Q1 2026, down 27.2% from $2.65 million a year earlier and down 26.7% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Research & Development (2011 - 2026) Analysis & Trends
On a TTM basis, BioRestorative Therapies' Research & Development came in at $9.37 million as of Mar 31, 2026, up 29.2% year-over-year; for FY2025, it was $10.09 million, up 50.5% from FY2024.
- Annual Research & Development has increased for four straight years, with a five-year compound annual growth rate of 63.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $6.71 million in FY2024 (+66.2%), $4.03 million in FY2023 (+14.8%), $3.51 million in FY2022 (+381.9%) and $729,058 in FY2021 (-16.9%).
- The Q1 2026 figure is the lowest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development rose in seven of the last eight quarters, with growth averaging 63.2%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 568.3% in Q2 2022, against a decline of 38.5% in Q2 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.63 million (Q4 2025), $2.59 million (Q3 2025) and $2.23 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 1.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 2.63 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 809,824.00 |
| Jun 30, 2023 | 902,891.00 |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 673,621.00 |
| Sep 30, 2022 | 989,170.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 775,337.00 |
| Dec 31, 2021 | 165,496.00 |
| Sep 30, 2021 | 237,410.00 |
| Jun 30, 2021 | 160,898.00 |
API Access
BioRestorative Therapies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();